申请人:Nakagawa Tadakiyo
公开号:US20090258900A1
公开(公告)日:2009-10-15
Amide derivatives represented by the formula (I):
wherein:
A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb′)m-, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, -ZR18 and the like, Z is —O—, —S(O)p-, —S(O)pO—, —NH—, —NR19-, and the like; or a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.
式(I)所表示的酰胺衍生物,其中:A是环烷基团、芳基团或杂环芳基团;X是氮原子或CR17;Y是—NRa—、—(CRbRb′)m-等;m为0至4;R1至R17可能相同或不同,每个都是氢原子、卤素原子、氰基、硝基、羧基、甲酰基、羟基、铵基、可选具有一个或多个取代基的烷基、-ZR18等,Z是—O—、—S(O)p-、—S(O)pO—、—NH—、—NR19-等;或其药学上可接受的盐、水合物或溶剂化物可用于药物的使用,例如抗炎和镇痛作用等。